Abstract:Since the advent of coronary stents, two of the most common long-term complications after percutaneous coronary intervention (PCI) are in-stent restenosis (ISR) and stent thrombosis (ST). Although the rates of ST have been nearly abolished and ISR rates have declined with the current gold-standard second-generation drug-eluting stents (DES), late ISR of DES remains a valid concern in the field of interventional cardiology. The drug-coated balloon (DCB) is a non-stent technology that relies on the concept of targeted homogeneous drug delivery from an inflated balloon to restore luminal vascularity, treat atherosclerosis, and overcome some limitations of PCI, including ISR and prolonged dual antiplatelet therapy to prevent ST by leaving nothing behind. Most clinical evidence on coronary DCBs predominantly comes from small, randomized data and registries using paclitaxel DCBs for ISR and de novo lesions in the coronary space. Since 2014, outside the United States, DCBs have been approved for the treatment of ISR, with a class I recommendation by the European Society of Cardiology. The Food and Drug Administration very recently approved the Agent DCB to treat ISR in patients with coronary artery disease in the US. Additionally, recent randomized clinical data also showed DCB's safety and efficacy for the treatment of de novo small-vessel disease and high-bleeding-risk patients, while their role for other clinical situations including acute coronary syndrome, large-vessel disease, bifurcation lesions, and long-diffuse distal lesions is currently under investigation. Herein, we review the evidence-based role of DCBs in the treatment of coronary lesions and offer future perspectives.

Clinical application and research status of drug-coated balloon in percutaneous coronary intervention

China Expert Consensus on Clinical Application of the Drug-Coated Balloon

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Drug-Coated Balloons Applications in Interventional Cardiology

Research progress of drug eluting balloon in arterial circulatory system

Chinese expert consensus on the clinical application of drug-coated balloon (2nd Edition)

Application of drug-coated balloons in treatment of coronary small vessel diseases

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Novel application of drug-coated balloons in coronary heart disease: A narrative review

Drug Coated Balloons and Their Role in Bifurcation Coronary Angioplasty: Appraisal of the Current Evidence and Future Directions

The factors influencing the efficiency of drug-coated balloons

Application of Drug-coated Balloon in Coronary Bifurcation Lesions

[Research progress in coatings with active compounds and extracts of traditional Chinese medicines for coronary intervention devices]

Coronary drug-coated balloons: A comprehensive review of clinical applications and controversies

Benefits and Challenges of Drug-Coated Balloons in Peripheral Artery Disease: From Molecular Mechanisms to Clinical Practice

Drug-coated balloons for coronary artery disease: An updated review with future perspectives

Research Progress of Drug-Coated Balloons for the Treatment of Infrapopliteal Artery Disease

Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?

Retrospective analysis of the drug-coated balloon-only strategy for chronic total occlusion coronary lesions

[Research Progress of the Drug-Coated Stents].

Clinical Efficacy and Safety of Drug Coated Balloon for Treating In-Stent Restenosis of Left Anterior Descend?ing Complex Artery Lesion in Coronary